-
The baseline characteristics of the follow-up population are shown in Table 1. A total of 2,892 individuals were recruited, and more than half of them were women (63.8%). Simultaneously, the women had a younger age, fewer school years, lesser personal monthly income, higher rural living percentage, higher smoking status, higher alcohol-drinking status, hypertension, higher BMI, lower FPG and UA median, and higher 2 h PG results compared with men (P all < 0.05). After 3.0 years of follow-up, 114 men (10.9%) and 172 women (9.3%) were diagnosed with T2DM.
Table 1. Baseline characteristics of the follow-up population
Characteristics Men Women P-value Number, (%) 1,046 (36.2) 1,846 (63.8) < 0.001 Age, (years) 52.1 ± 11.0 50.3 ± 9.7 < 0.001 School years > 9, n (%) 255 (24.4) 365 (19.8) 0.003 Unmarried, n (%) 58 (5.6) 86 (4.7) 0.286 Rural living, n (%) 867 (82.9) 1,410 (76.4) < 0.001 Personal monthly income, n (%) < 0.001 ≤ 599 476 (46.9) 1,113 (62.7) 600–1,999 435 (42.9) 621 (35.0) ≥ 2,000 103 (10.2) 41 (2.3) Family history of diabetes, n (%) 105 (10.3) 210 (11.5) 0.318 T2DM in the follow-up survey, n (%) 114 (10.9) 172 (9.3) 0.171 Follow-up duration (years) 3.14 3.19 0.174 Current smoking, n (%) 594 (57.1) 62 (3.4) < 0.001 Current alcohol-drinking status, n (%) 449 (43.1) 16 (0.9) < 0.001 BMI (kg/m2) 24.9 ± 3.4 25.5 ± 3.6 < 0.001 Hypertension, n (%) 518 (50.0) 802 (43.9) 0.002 TG (mmol/L) 1.03 (0.74, 1.56) 1.08 (0.77, 1.60) 0.267 TC (mmol/L) 5.16 (4.58, 5.77) 5.14 (4.56, 5.83) 0.843 FPG (mmol/L) 5.6 (5.2, 6.1) 5.5 (5.1, 5.9) < 0.001 2 h PG (mmol/L) 6.2 (5.1, 7.5) 6.5 (5.6, 7.7) < 0.001 HDL-C (mmol/L) 1.57 (1.34, 1.87) 1.60 (1.38, 1.85) 0.059 UA (μmol/L) 341 (294, 395) 267 (228, 311) < 0.001 Note. BMI, body mass index; T2DM, type 2 diabetes mellitus; TG, triglycerides; TC, total cholesterol; FPG, fasting plasma glucose; 2 h PG, 2-hour post-load plasma glucose; HDL-C, high-density lipoprotein cholesterol; UA, uric acid. As shown in Figure 2, higher TG at baseline indicated significantly increased T2DM incidence in women (Ptrend < 0.001) but not in men (P = 0.101). However, higher TC showed significantly increased T2DM incidence in both men (Ptrend = 0.029) and women (Ptrend < 0.001).
Figure 2. The incidence (%) of type 2 diabetes mellitus in men and women based on the triglycerides (TG) and total cholesterol (TC) levels
Cox regression results were presented in Table 2. Univariate Cox regression showed that higher TG [BHTG (HR: 2.05; 95% CI: 1.40, 3.00), hypertriglyceridemia (HR: 2.64; 95% CI: 1.68, 4.15)] and TC [hypercholesterolemia (HR: 2.05; 95% CI: 1.43, 2.95)] were significantly associated with increased risk of T2DM incidence in women but not in men. Only elevated TC [BHTC (HR: 1.61, 95% CI: 1.04, 2.48)] showed increased risk of T2DM in men even after adjusting for age, BMI, family history of diabetes, school years, marital status, geographic division, personal monthly income, smoking status, alcohol-drinking status, hypertension, HDL-C, and UA. Elevated TG [(hypertriglyceridemia (HR: 1.78; 95% CI: 1.07, 2.97)] and TC [hypercholesterolemia (HR: 1.68; 95% CI: 1.81, 2.61)] still indicated significant association in women in multivariate Cox regression analysis.
Table 2. HR and 95% CI of triglycerides and total cholesterol for type 2 diabete mellitus incidence in men and women in Cox regression models
Varaibles N Model 1 Model 2 Men Triglycerides (mmol/L) < 4.1 817 1.00 1.00 4.1–4.9 110 1.12 (0.63, 2.02) 1.21 (0.64, 2.31) ≥ 4.9 119 1.42 (0.85, 2.37) 1.77 (0.97, 2.97) Total cholesterol (mmol/L) < 5.2 532 1.00 1.00 5.2–6.2 366 1.49 (1.00, 2.24) 1.61 (1.04, 2.48) ≥ 6.2 148 1.54 (0.91, 2.61) 1.44 (0.82, 2.52) Women Triglycerides (mmol/L) < 4.1 1,434 1.00 1.00 4.1–4.9 255 2.05 (1.40, 3.00) 1.29 (0.84, 1.99) ≥ 4.9 157 2.64 (1.68, 4.15) 1.78 (1.07, 2.97) Total cholesterol (mmol/L) < 5.2 969 1.00 1.00 5.2–6.2 586 1.09 (0.76, 1.56) 0.93 (0.62, 1.39) ≥ 6.2 291 2.05 (1.43, 2.95) 1.68 (1.81, 2.61) Note. Model 1: univariate Cox regression. Model 2: adjusted for age, body mass index (BMI), family history of diabetes, school years, marital status, geographic division, personal monthly income, smoking status, alcohol-drinking status, hypertension, high-density lipoprotein cholesterol (HDL-C), and uric acid (UA). HR, hazard ratio; 95% CI, 95% confidence interval. AUROCs of TG and TC for T2DM incidence are presented in Figure 3. AUROCs of TG and TC in women were 0.60 (0.58–0.62) and 0.59 (0.56–0.61), respectively, with P < 0.001, and P > 0.05 for men. But the AUROCs of TG and TC predicting T2DM incidence were not significantly different in men and women.
Figure 3. Receiver operating characteristic (ROC) of triglycerides (TG), total cholesterol (TC) predicting type 2 diabetes mellitus (T2DM) incidence in men and women
The optimal cutoff values, sensitivity, specificity, and accuracy of actually identifying subjects with type 2 diabetes for TG and TC are presented in Table 3. The optimal cutoff values of TG and TC were > 1.15 and > 5.17 mmol/L in men, respectively, with low sensitivity [TG: 53.5% (43.9%, 62.9%) TC: 60.5% (50.9%, 69.6%)], low specificity [TG: 58.6% (55.3%, 61.8%); TC: 52.0% (48.8%, 55.3%)], and minimal practical utility [LR+: TG, 1.29 (1.10, 1.60) and TC, 1.26 (1.10, 1.50); LR−: TG, 0.79 (0.60, 1.00) and TC, 0.76 (0.60, 1.00)]. The cutoff values of TG and TC in women were the same as in men with low sensitivity, specificity, and minimal practical utility.
Table 3. AUROC, optimal cutoff value (mmol/L), sensitivity (%), specificity (%), and accuracy of actually identifying subjects with T2DM
Items AUROC Cut off (mmol/L) Sensitivity (95% CI) Specificity (95% CI) LR+ (95% CI) LR− (95% CI) Men TG 0.54 (0.51, 0.58) > 1.15 53.51 (43.9, 62.9) 58.58 (55.3, 61.8) 1.29 (1.10, 1.60) 0.79 (0.60, 1.00) TC 0.55 (0.52, 0.58) > 5.17 60.53 (50.9, 69.6) 52.04 (48.8, 55.3) 1.26 (1.10, 1.50) 0.76 (0.60, 1.00) Women TG 0.60 (0.58, 0.62) > 1.23 58.14 (50.4, 65.6) 61.65 (59.3, 64.0) 1.52 (1.30, 1.70) 0.68 (0.60, 0.80) TC 0.59 (0.57, 0.61) > 5.77 41.28 (33.8, 49.0) 75.15 (73.0, 77.2) 1.66 (1.40, 2.00) 0.78 (0.70, 0.90) Note. AUROC, area under receiver operating characteristic; T2DM, type 2 diabetes mellitus; 95% CI, 95% confidence interval; LR+, positive likelihood ratio; LR–, negative likelihood ratio.
doi: 10.3967/bes2019.113
The Ability of Baseline Triglycerides and Total Cholesterol Concentrations to Predict Incidence of Type 2 Diabetes Mellitus in Chinese Men and Women: A Longitudinal Study in Qingdao, China
-
Abstract:
Objectives The purpose of this study was to assess the association between triglycerides (TG), total cholesterol (TC) at baseline, and type 2 diabetes mellitus (T2DM) incidence in a general Chinese population. Further, it aimed to evaluate the ability of TG and TC to predict T2DM incidence. Methods Qingdao Diabetes Prevention Program participants recruited between 2006 and 2009 were followed up in 2012–2015. TG, TC, and T2DM status were measured. Cox proportional hazards models were used to estimate the association between TG, TC, and T2DM incidence. The receiver operating characteristic (ROC) curve was used to evaluate the ability of TG and TC to identify T2DM participants. Results The incidence of T2DM significantly increased with TG in women and TC in both men and women (Ptrend < 0.05). Univariate Cox regression indicated that higher TG {borderline high TG [hazards ratio (HR): 2.05; 95% confidence interval (CI): 1.40, 3.00] and hypertriglyceridemia [HR: 2.64; 95% CI: 1.68, 4.15]} and TC [hypercholesterolemia (HR: 2.05; 95% CI: 1.43, 2.95)] were significantly associated with increased risk of T2DM incidence in women but not in men. Multivariate Cox regression showed that hypertriglyceridemia in women (HR: 1.78, 95% CI: 1.07, 2.97), borderline high TC in men (HR: 1.61, 95% CI: 1.04, 2.48), and hypercholesterolemia in women (HR: 1.68, 95% CI: 1.81, 2.61) had a higher significant risk of T2DM incidence. The optimal cutoff values of TG were > 1.15 and > 1.23 mmol/L in men and women, respectively. For TC, they were > 5.17 and > 5.77 mmol/L in men and women, respectively. The area under the ROCs of TG and TC were 0.54 (0.51–0.57) and 0.55 (0.52–0.58), respectively, in men, and 0.60 (0.58–0.62) and 0.59 (0.56–0.61), respectively, in women. Conclusion Elevated TG and TC were risk factors for T2DM incidence. However, no predictive capacity was found for both factors to identify T2DM incidence in Chinese men and women. Hence, TG and TC levels in both Chinese men and women might be used for decreasing the incidence of T2DM but no clinical predictive capacity for T2DM. -
Key words:
- Triglycerides /
- Total cholesterol /
- Adult onset type 2 diabetes mellitus
-
Table 1. Baseline characteristics of the follow-up population
Characteristics Men Women P-value Number, (%) 1,046 (36.2) 1,846 (63.8) < 0.001 Age, (years) 52.1 ± 11.0 50.3 ± 9.7 < 0.001 School years > 9, n (%) 255 (24.4) 365 (19.8) 0.003 Unmarried, n (%) 58 (5.6) 86 (4.7) 0.286 Rural living, n (%) 867 (82.9) 1,410 (76.4) < 0.001 Personal monthly income, n (%) < 0.001 ≤ 599 476 (46.9) 1,113 (62.7) 600–1,999 435 (42.9) 621 (35.0) ≥ 2,000 103 (10.2) 41 (2.3) Family history of diabetes, n (%) 105 (10.3) 210 (11.5) 0.318 T2DM in the follow-up survey, n (%) 114 (10.9) 172 (9.3) 0.171 Follow-up duration (years) 3.14 3.19 0.174 Current smoking, n (%) 594 (57.1) 62 (3.4) < 0.001 Current alcohol-drinking status, n (%) 449 (43.1) 16 (0.9) < 0.001 BMI (kg/m2) 24.9 ± 3.4 25.5 ± 3.6 < 0.001 Hypertension, n (%) 518 (50.0) 802 (43.9) 0.002 TG (mmol/L) 1.03 (0.74, 1.56) 1.08 (0.77, 1.60) 0.267 TC (mmol/L) 5.16 (4.58, 5.77) 5.14 (4.56, 5.83) 0.843 FPG (mmol/L) 5.6 (5.2, 6.1) 5.5 (5.1, 5.9) < 0.001 2 h PG (mmol/L) 6.2 (5.1, 7.5) 6.5 (5.6, 7.7) < 0.001 HDL-C (mmol/L) 1.57 (1.34, 1.87) 1.60 (1.38, 1.85) 0.059 UA (μmol/L) 341 (294, 395) 267 (228, 311) < 0.001 Note. BMI, body mass index; T2DM, type 2 diabetes mellitus; TG, triglycerides; TC, total cholesterol; FPG, fasting plasma glucose; 2 h PG, 2-hour post-load plasma glucose; HDL-C, high-density lipoprotein cholesterol; UA, uric acid. Table 2. HR and 95% CI of triglycerides and total cholesterol for type 2 diabete mellitus incidence in men and women in Cox regression models
Varaibles N Model 1 Model 2 Men Triglycerides (mmol/L) < 4.1 817 1.00 1.00 4.1–4.9 110 1.12 (0.63, 2.02) 1.21 (0.64, 2.31) ≥ 4.9 119 1.42 (0.85, 2.37) 1.77 (0.97, 2.97) Total cholesterol (mmol/L) < 5.2 532 1.00 1.00 5.2–6.2 366 1.49 (1.00, 2.24) 1.61 (1.04, 2.48) ≥ 6.2 148 1.54 (0.91, 2.61) 1.44 (0.82, 2.52) Women Triglycerides (mmol/L) < 4.1 1,434 1.00 1.00 4.1–4.9 255 2.05 (1.40, 3.00) 1.29 (0.84, 1.99) ≥ 4.9 157 2.64 (1.68, 4.15) 1.78 (1.07, 2.97) Total cholesterol (mmol/L) < 5.2 969 1.00 1.00 5.2–6.2 586 1.09 (0.76, 1.56) 0.93 (0.62, 1.39) ≥ 6.2 291 2.05 (1.43, 2.95) 1.68 (1.81, 2.61) Note. Model 1: univariate Cox regression. Model 2: adjusted for age, body mass index (BMI), family history of diabetes, school years, marital status, geographic division, personal monthly income, smoking status, alcohol-drinking status, hypertension, high-density lipoprotein cholesterol (HDL-C), and uric acid (UA). HR, hazard ratio; 95% CI, 95% confidence interval. Table 3. AUROC, optimal cutoff value (mmol/L), sensitivity (%), specificity (%), and accuracy of actually identifying subjects with T2DM
Items AUROC Cut off (mmol/L) Sensitivity (95% CI) Specificity (95% CI) LR+ (95% CI) LR− (95% CI) Men TG 0.54 (0.51, 0.58) > 1.15 53.51 (43.9, 62.9) 58.58 (55.3, 61.8) 1.29 (1.10, 1.60) 0.79 (0.60, 1.00) TC 0.55 (0.52, 0.58) > 5.17 60.53 (50.9, 69.6) 52.04 (48.8, 55.3) 1.26 (1.10, 1.50) 0.76 (0.60, 1.00) Women TG 0.60 (0.58, 0.62) > 1.23 58.14 (50.4, 65.6) 61.65 (59.3, 64.0) 1.52 (1.30, 1.70) 0.68 (0.60, 0.80) TC 0.59 (0.57, 0.61) > 5.77 41.28 (33.8, 49.0) 75.15 (73.0, 77.2) 1.66 (1.40, 2.00) 0.78 (0.70, 0.90) Note. AUROC, area under receiver operating characteristic; T2DM, type 2 diabetes mellitus; 95% CI, 95% confidence interval; LR+, positive likelihood ratio; LR–, negative likelihood ratio. -
[1] HUANG Y. IDF Diabetes Atlas 8th Edition. International Diabetes Federation, 2017; 41. [2] XU Y, WANG L, HE J, et al. Prevalence and control of diabetes in Chinese adults. JAMA, 2013; 310, 948−59. doi: 10.1001/jama.2013.168118 [3] GOLDBERG RB, KENDALL DM, DEEG MA, et al. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabetes Care, 2005; 28, 1547−54. doi: 10.2337/diacare.28.7.1547 [4] KRAUSS R M, SIRI P W. Dyslipidemia in type 2 diabetes. Med Clin North Am, 2004; 88, 897−909. doi: 10.1016/j.mcna.2004.04.004 [5] ZHANG L, QIAO Q, TUOMILEHTO J, et al. Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: the DECODE Study. Diabetes Res Clin Pract, 2008; 82, 364−77. doi: 10.1016/j.diabres.2008.08.022 [6] YANG W, LU J, WENG J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010; 362, 1090−101. doi: 10.1056/NEJMoa0908292 [7] TIROSH A, SHAI I, BITZUR R, et al. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care, 2008; 31, 2032−7. doi: 10.2337/dc08-0825 [8] PERRY IJ, WANNAMETHEE SG, WALKER MK, et al. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ, 1995; 310, 560−4. doi: 10.1136/bmj.310.6979.560 [9] CHRISTIAN JB, BOURGEOIS N, SNIPES R, et al. Prevalence of severe (500 to 2,000 mg/dl) hypertriglyceridemia in United States adults. Am J Cardiol, 2011; 107, 891−7. doi: 10.1016/j.amjcard.2010.11.008 [10] RHEE EJ, HAN K, KO SH, et al. Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: A nationwide population-based study. PLoS One, 2017; 12, e176615. [11] SEO MH, BAE JC, PARK SE, et al. Association of lipid and lipoprotein profiles with future development of type 2 diabetes in nondiabetic Korean subjects: a 4-year retrospective, longitudinal study. J Clin Endocrinol Metab, 2011; 96, E2050−4. doi: 10.1210/jc.2011-1857 [12] CUI J, SUN J, WANG W, et al. The association of triglycerides and total cholesterol concentrations with newly diagnosed diabetes in adults in China. Oncotarget, 2017; 8, 103477−85. [13] ALMAJWAL AM, AL-BAGHLI NA, BATTERHAM MJ, et al. Performance of body mass index in predicting diabetes and hypertension in the Eastern Province of Saudi Arabia. Ann Saudi Med, 2009; 29, 437−45. doi: 10.4103/0256-4947.57165 [14] XIAO X, LIU Y, SUN C, et al. Evaluation of different obesity indices as predictors of type 2 diabetes mellitus in a Chinese population. J Diabetes, 2015; 7, 386−92. doi: 10.1111/1753-0407.12201 [15] DOTEVALL A, JOHANSSON S, WILHELMSEN L, et al. Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study. Diabet Med, 2004; 615−22. [16] MCPHILLIPS JB, BARRETT-CONNOR E, WINGARD DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol, 1990; 131, 443−53. doi: 10.1093/oxfordjournals.aje.a115519 [17] KANAYA AM, WASSEL FC, de REKENEIRE N, et al. Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care, 2005; 28, 404−8. doi: 10.2337/diacare.28.2.404 [18] HADAEGH F, HATAMI M, TOHIDI M, et al. Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women. Lipids Health Dis, 2010; 9, 85. doi: 10.1186/1476-511X-9-85 [19] HE S, WANG S, CHEN X, et al. Higher ratio of triglyceride to high-density lipoprotein cholesterol may predispose to diabetes mellitus: 15-year prospective study in a general population. Metabolism, 2012; 61, 30−6. doi: 10.1016/j.metabol.2011.05.007 [20] KOMPOTI M, MARIOLIS A, ALEVIZOS A, et al. Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes. Cardiovasc Diabetol, 2006; 5, 21. doi: 10.1186/1475-2840-5-21 [21] QIAO Q, PANG Z, GAO W, et al. A large-scale diabetes prevention program in real-life settings in Qingdao of China (2006-2012). Prim Care Diabetes, 2010; 4, 99−103. doi: 10.1016/j.pcd.2010.04.003 [22] Institute Of Cellular Medicine. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva World Health Organization, 2006. [23] Joint Committee For Developing Adults. Guidelines on prevention and treatment of blood lipid abnormality in Chinese adults (Revised in 2016). Chinese Circulation Journal, 2016; 31, 937−53. [24] GAO WG, DONG YH, PANG ZC, et al. Increasing trend in the prevalence of Type 2 diabetes and pre-diabetes in the Chinese rural and urban population in Qingdao, China. Diabet Med, 2009; 26, 1220−7. doi: 10.1111/j.1464-5491.2009.02832.x [25] SWETS JA. Measuring the accuracy of diagnostic systems. Science, 1988; 240, 1285−93. doi: 10.1126/science.3287615 [26] WANG YL, KOH WP, TALAEI M, et al. Association between the ratio of triglyceride to high-density lipoprotein cholesterol and incident type 2 diabetes in Singapore Chinese men and women. J Diabetes, 2017; 9, 689−98. doi: 10.1111/1753-0407.12477 [27] ALBERTI KG, ECKEL RH, GRUNDY SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009; 120, 1640−5. doi: 10.1161/CIRCULATIONAHA.109.192644 [28] UNGER RH, ZHOU YT. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes, 2001; 50(Suppl 1), S118−21. [29] LI N, FU J, KOONEN DP, et al. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance? Atherosclerosis, 2014; 233, 130−8. doi: 10.1016/j.atherosclerosis.2013.12.013 [30] ONAT A, CAN G. Enhanced proinflammatory state and autoimmune activation: a breakthrough to understanding chronic diseases. Curr Pharm Des, 2014; 20, 575−84. doi: 10.2174/138161282004140213145551 [31] ARAZ AM. Sleep Disorders and Attention Deficit: A Consequence of Proinflammatory State? J Clin Sleep Med, 2018; 14, 1081. doi: 10.5664/jcsm.7190 [32] QI Q, LIANG L, DORIA A, et al. Genetic predisposition to dyslipidemia and type 2 diabetes risk in two prospective cohorts. Diabetes, 2012; 61, 745−52. doi: 10.2337/db11-1254